Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in...
Read More »Proof-of-concept data for a novel exosome-based cancer detection platform published
Peregrine Pharmaceuticals, Inc., a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical companies and advancing its proprietary R&D pipeline, today announced the publication of positive proof-of-concept data for a novel exosome-based cancer detection ...
Read More »Seeking Cancer Clues in Blood, Researchers Explore Exosomes
A growing number of researchers and some biotech companies are exploring ways to use tiny vesicles called exosomes, which are released into the blood by cells, to gain insights into cancer and to develop clinical tools for patients. Recent studies ...
Read More »Circulating exosomes cause tumor malignancy in a chronic sleep fragmentation model
Chronic sleep fragmentation (SF) increases cancer aggressiveness in mice. Exosomes exhibit pleiotropic biological functions, including immune regulatory functions, antigen presentation, intracellular communication and inter-cellular transfer of RNA and proteins. University of Chicago researchers hypothesized that SF-induced alterations in biosynthesis and ...
Read More »A novel “salting-out” procedure for the isolation of tumor-derived exosomes
The last decade has seen an exponential growth in the number of exosome-related publications. Although many of these studies have used exosomes from biological fluids (blood, and ascites or pleural effusions) the vast majority employed vesicles isolated from large volumes ...
Read More »